UPS (NYSE:UPS) today announced a series of facility expansions to its healthcare-dedicated warehouse and distribution network in key global markets. This includes new GDP-compliant space opening in Central and Eastern Europe and additional cold chain space coming online near its UPS Worldport® facility in Louisville. The company is planning up to 1.5 million sq. ft. of cGMP distribution space for Coronavirus-related shipments, and a new facility in Shanghai.
“UPS Healthcare continues to build out a global distribution infrastructure that demonstrates our commitment to the healthcare industry,” said Wes Wheeler, UPS Healthcare president. “We will continue to innovate and expand our quality systems throughout our expanded network to further support more complex pharmaceutical and lab testing requirements.”
As part of these ongoing facility enhancements, the company has committed to building additional cooler space (2-8 degrees Celsius), and freezer space (minus-20 degrees to minus-80 degrees Celsius) in its new GMP facility in Louisville. UPS Healthcare is also expanding its GDP facility space in Hungary, and GMP space in the United Kingdom through its Polar Speed subsidiary where it operates a dispensing pharmacy that serves more than 20,000 patients daily. The new GMP warehouse and transportation hub will be located in the Midlands, UK, to further facilitate its clients’ growth needs.
